Literature DB >> 33534524

Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion.

Mona D Doshi1, Elisa J Gordon2, Barry I Freedman3, Craig Glover4, Jayme E Locke5, Christie P Thomas6,6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33534524      PMCID： PMC8994118          DOI： 10.1097/TP.0000000000003641

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  16 in total

1.  You Are Just Now Telling Us About This? African American Perspectives of Testing for Genetic Susceptibility to Kidney Disease.

Authors:  Ebele M Umeukeje; Bessie A Young; Stephanie M Fullerton; Kerri Cavanaugh; Delia Owens; James G Wilson; Wylie Burke; Erika Blacksher
Journal:  J Am Soc Nephrol       Date:  2019-03-11       Impact factor: 10.121

2.  Quantifying Postdonation Risk of ESRD in Living Kidney Donors.

Authors:  Allan B Massie; Abimereki D Muzaale; Xun Luo; Eric K H Chow; Jayme E Locke; Anh Q Nguyen; Macey L Henderson; Jon J Snyder; Dorry L Segev
Journal:  J Am Soc Nephrol       Date:  2017-04-27       Impact factor: 10.121

3.  Worldwide Frequencies of APOL1 Renal Risk Variants.

Authors:  Girish N Nadkarni; Christopher R Gignoux; Elena P Sorokin; Michelle Daya; Rayees Rahman; Kathleen C Barnes; Christina L Wassel; Eimear E Kenny
Journal:  N Engl J Med       Date:  2018-12-27       Impact factor: 91.245

Review 4.  Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.

Authors:  Barry I Freedman; Karl Skorecki
Journal:  Clin J Am Soc Nephrol       Date:  2014-06-05       Impact factor: 8.237

Review 5.  APOL1 Genetic Testing in Living Kidney Transplant Donors.

Authors:  Sumit Mohan; Ana S Iltis; Deirdre Sawinski; James M DuBois
Journal:  Am J Kidney Dis       Date:  2019-04-11       Impact factor: 8.860

Review 6.  Apolipoprotein L1 and Kidney Disease in African Americans.

Authors:  David J Friedman; Martin R Pollak
Journal:  Trends Endocrinol Metab       Date:  2016-03-03       Impact factor: 12.015

7.  APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.

Authors:  Barry I Freedman; Stephen O Pastan; Ajay K Israni; David Schladt; Bruce A Julian; Michael D Gautreaux; Vera Hauptfeld; Robert A Bray; Howard M Gebel; Allan D Kirk; Robert S Gaston; Jeffrey Rogers; Alan C Farney; Giuseppe Orlando; Robert J Stratta; Sumit Mohan; Lijun Ma; Carl D Langefeld; Donald W Bowden; Pamela J Hicks; Nicholette D Palmer; Amudha Palanisamy; Amber M Reeves-Daniel; W Mark Brown; Jasmin Divers
Journal:  Transplantation       Date:  2016-01       Impact factor: 4.939

8.  African American Living Donors' Attitudes About APOL1 Genetic Testing: A Mixed Methods Study.

Authors:  Elisa J Gordon; Daniela Amόrtegui; Isaac Blancas; Catherine Wicklund; John Friedewald; Richard R Sharp
Journal:  Am J Kidney Dis       Date:  2018-10-22       Impact factor: 8.860

9.  Variation of ApoL1 Testing Practices for Living Kidney Donors.

Authors:  Tristan McIntosh; Sumit Mohan; Deirdre Sawinski; Ana Iltis; James M DuBois
Journal:  Prog Transplant       Date:  2019-12-16       Impact factor: 1.187

10.  Opinions of African American adults about the use of apolipoprotein L1 (ApoL1) genetic testing in living kidney donation and transplantation.

Authors:  Margaret Berrigan; Jasmine Austrie; Aaron Fleishman; Kenneth P Tercyak; Martin R Pollak; Martha Pavlakis; Vinayak Rohan; Prabhakar K Baliga; Liise K Kayler; Thomas H Feeley; James R Rodrigue
Journal:  Am J Transplant       Date:  2020-08-29       Impact factor: 8.086
View more
  1 in total

1.  Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.

Authors:  Yasar Caliskan; Brian Lee; Adrian Whelan; Fadee Abualrub; Krista L Lentine; Arksarapuk Jittirat
Journal:  Curr Transplant Rep       Date:  2022-03-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.